{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:34:46Z","timestamp":1789655686747,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["T32 CA180984"],"award-info":[{"award-number":["T32 CA180984"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.urolonc.2025.05.005","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T07:19:46Z","timestamp":1747984786000},"page":"527.e1-527.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Incidence and prevention strategies for postprostate biopsy infections in the United States from 2012 to 2021"],"prefix":"10.1016","volume":"43","author":[{"given":"Adithya","family":"Balasubramanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6438-0872","authenticated-orcid":false,"given":"Gal","family":"Wald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Gurayah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"Arenas-Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Millot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Dreyfuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Shoag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Lewicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"876","key":"10.1016\/j.urolonc.2025.05.005_bib0001","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","article-title":"Systematic review of complications of prostate biopsy","volume":"64","author":"Loeb","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0002","doi-asserted-by":"crossref","first-page":"ofw265","DOI":"10.1093\/ofid\/ofw265","article-title":"Infection-related hospital admissions after prostate biopsy in United States men","volume":"4","author":"Evans","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0003","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.juro.2011.06.057","article-title":"Complications after prostate biopsy: data from SEER-Medicare","volume":"186","author":"Loeb","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0004","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.juro.2017.01.103","article-title":"An update of the American Urological Association White Paper on the prevention and treatment of the more common complications related to prostate biopsy","volume":"198","author":"Liss","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0005","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.juro.2009.11.043","article-title":"Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy","volume":"183","author":"Nam","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0006","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.eururo.2012.04.044","article-title":"Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis?","volume":"62","author":"Carignan","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0007","first-page":"2018","article-title":"Screening for prostate cancer: US preventive services task force recommendation statement","volume":"319","author":"Force","year":"1901","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0008","unstructured":"Force USPST: Is prostate cancer screening right for you? https:\/\/www.uspreventiveservicestaskforce.org\/Home\/GetFileByToken\/HV9RGq3wLyh6PyK4oxVtde"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0009","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.eururo.2020.11.011","article-title":"Problems with numbers in decision aids for prostate-specific antigen screening: a critical review","volume":"79","author":"Carlsson","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0010","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/JU.0000000000000814","article-title":"Antibiotic prophylaxis for the prevention of infectious complications following prostate biopsy: a systematic review and meta-analysis","volume":"204","author":"Pilatz","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0011","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12957-019-1573-0","article-title":"Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis","volume":"17","author":"Xiang","year":"2019","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0012","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.euf.2018.11.009","article-title":"Update on strategies to reduce infectious complications after prostate biopsy","volume":"5","author":"Pilatz","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0013","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S1473-3099(22)00373-5","article-title":"Antibiotic prophylaxis versus no antibiotic prophylaxis in transperineal prostate biopsies (NORAPP): a randomised, open-label, non-inferiority trial","volume":"22","author":"Jacewicz","year":"2022","journal-title":"The Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.urolonc.2025.05.005_bib0014","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1001\/jamaoncol.2024.4000","article-title":"Transperineal vs transrectal prostate biopsy-the PREVENT randomized clinical trial","volume":"10","author":"Hu","year":"2024","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2025.05.005_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.eururo.2022.01.046","article-title":"Transperineal prostate biopsy is the new black: what are the next targets?","volume":"82","author":"Lenfant","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0016","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG Guidelines on prostate Cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0017","unstructured":"Merative: Marketscan research databases for life sciences researchers.https:\/\/assets.merative.com\/m\/1d62943b61ba8564\/original\/Marketscan_Research-databases-for-life-sciences-researchers_Solution-Brief.PDF"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0018","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/MLR.0000000000000735","article-title":"Identifying increased risk of readmission and In-hospital mortality using hospital administrative data: the AHRQ Elixhauser comorbidity Index","volume":"55","author":"Moore","year":"2017","journal-title":"Med Care"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0019","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2337\/dc10-1185","article-title":"Diabetes and sepsis: preclinical findings and clinical relevance","volume":"34","author":"Schuetz","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0020","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1097\/MLR.0b013e318268ac86","article-title":"Identifying patients with severe sepsis using administrative claims: patient-level validation of the Angus implementation of the International Consensus Conference definition of severe sepsis","volume":"52","author":"Iwashyna","year":"2014","journal-title":"Med Care"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0021","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0022","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/CCM.0b013e318232db65","article-title":"Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007","volume":"40","author":"Lagu","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0023","first-page":"e0970","article-title":"Sepsis-2.5: resolving conflicts between payers and providers","volume":"5","author":"Rodenberg","year":"2023","journal-title":"Critical Care Explorat"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0024","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/CCM.0000000000001751","article-title":"Sepsis to the fore: taking the lead in critical care admissions","volume":"44","author":"Kempker","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0025","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/JU.0000000000000509","article-title":"Best practice statement on urologic procedures and antimicrobial prophylaxis","volume":"203","author":"Lightner","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0026","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.juro.2010.11.088","article-title":"Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy","volume":"185","author":"Liss","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0027","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.juro.2014.08.008","article-title":"Fluoroquinolone resistance in the rectal carriage of men in an active surveillance cohort: longitudinal analysis","volume":"193","author":"Cohen","year":"2015","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0028","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.juro.2012.08.194","article-title":"Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis","volume":"189","author":"Adibi","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2025.05.005_bib0029","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/JU.0000000000003788","article-title":"Complications following transrectal and transperineal prostate biopsy: results of the ProBE-PC randomized clinical trial","volume":"211","author":"Mian","year":"2024","journal-title":"J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925001772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925001772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T11:36:48Z","timestamp":1754912208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925001772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1078143925001772"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.05.005","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and prevention strategies for postprostate biopsy infections in the United States from 2012 to 2021","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}